Cargando…

High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China

BACKGROUND: The overall success of Human immunodeficiency virus type 1 (HIV-1) antiretroviral therapy (ART) was heavily challenged upon the occurrence of drug resistance. Dehong Prefecture witnessed not only the first report of HIV-1 infection but also the experimental adoption of antiviral treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xuan, Qicai, Liang, Shuwen, Qin, Weihong, Yang, Shuting, Zhang, A-mei, Zhao, Ting, Su, Hui, Xia, Zhiqing, Wang, Binghui, Xia, Xueshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941624/
https://www.ncbi.nlm.nih.gov/pubmed/29739342
http://dx.doi.org/10.1186/s12879-018-3130-9
_version_ 1783321323318018048
author Xuan, Qicai
Liang, Shuwen
Qin, Weihong
Yang, Shuting
Zhang, A-mei
Zhao, Ting
Su, Hui
Xia, Zhiqing
Wang, Binghui
Xia, Xueshan
author_facet Xuan, Qicai
Liang, Shuwen
Qin, Weihong
Yang, Shuting
Zhang, A-mei
Zhao, Ting
Su, Hui
Xia, Zhiqing
Wang, Binghui
Xia, Xueshan
author_sort Xuan, Qicai
collection PubMed
description BACKGROUND: The overall success of Human immunodeficiency virus type 1 (HIV-1) antiretroviral therapy (ART) was heavily challenged upon the occurrence of drug resistance. Dehong Prefecture witnessed not only the first report of HIV-1 infection but also the experimental adoption of antiviral treatment in China. The transmission and epidemic of HIV-1 in Dehong is impacted by cross-border activities. The characteristics of HIV-1 drug resistance among therapy-naïve Burmese entering travelers in Yunnan and their speculated origin are still not clarified. METHODS: Two hundred ninety-eight HIV-1 infected Burmese entering travelers at Dehong ports were recruited between 2003 and 2012. The partial HIV-1 pol gene fragments were amplified and sequenced for the analysis of drug-resistance mutations (DRMs). Phylogenetic analysis on gag-pol gene was conducted to elucidate phylogenetic and evolutionary characteristics of these drug resistant strains. RESULTS: It was figured out that the occurrence ratio of HIV-1 drug resistance among HIV-1 infected entering travelers from Myanmar was up to 12.8%. The resistant mutations covered several types, including one type of PI mutations (L33F), six types of NRTI mutations and seven types of NNRTI. Close genetic relationship was observed in the phylogenetic analysis on gag-pol gene among the drug resistant strains respectively from Dehong, other Yunnan areas, neighboring provinces (Guangxi) and neighboring countries (Thailand and Myanmar). CONCLUSIONS: The findings in this study revealed that HIV drug resistant locus is spreading from the population who is receiving drug-resistance treatment to the new infectors, which indicates the urgency of surveillance work on drug resistance among the migrant population with high risks of HIV infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3130-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5941624
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59416242018-05-14 High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China Xuan, Qicai Liang, Shuwen Qin, Weihong Yang, Shuting Zhang, A-mei Zhao, Ting Su, Hui Xia, Zhiqing Wang, Binghui Xia, Xueshan BMC Infect Dis Research Article BACKGROUND: The overall success of Human immunodeficiency virus type 1 (HIV-1) antiretroviral therapy (ART) was heavily challenged upon the occurrence of drug resistance. Dehong Prefecture witnessed not only the first report of HIV-1 infection but also the experimental adoption of antiviral treatment in China. The transmission and epidemic of HIV-1 in Dehong is impacted by cross-border activities. The characteristics of HIV-1 drug resistance among therapy-naïve Burmese entering travelers in Yunnan and their speculated origin are still not clarified. METHODS: Two hundred ninety-eight HIV-1 infected Burmese entering travelers at Dehong ports were recruited between 2003 and 2012. The partial HIV-1 pol gene fragments were amplified and sequenced for the analysis of drug-resistance mutations (DRMs). Phylogenetic analysis on gag-pol gene was conducted to elucidate phylogenetic and evolutionary characteristics of these drug resistant strains. RESULTS: It was figured out that the occurrence ratio of HIV-1 drug resistance among HIV-1 infected entering travelers from Myanmar was up to 12.8%. The resistant mutations covered several types, including one type of PI mutations (L33F), six types of NRTI mutations and seven types of NNRTI. Close genetic relationship was observed in the phylogenetic analysis on gag-pol gene among the drug resistant strains respectively from Dehong, other Yunnan areas, neighboring provinces (Guangxi) and neighboring countries (Thailand and Myanmar). CONCLUSIONS: The findings in this study revealed that HIV drug resistant locus is spreading from the population who is receiving drug-resistance treatment to the new infectors, which indicates the urgency of surveillance work on drug resistance among the migrant population with high risks of HIV infection. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3130-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-08 /pmc/articles/PMC5941624/ /pubmed/29739342 http://dx.doi.org/10.1186/s12879-018-3130-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Xuan, Qicai
Liang, Shuwen
Qin, Weihong
Yang, Shuting
Zhang, A-mei
Zhao, Ting
Su, Hui
Xia, Zhiqing
Wang, Binghui
Xia, Xueshan
High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title_full High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title_fullStr High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title_full_unstemmed High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title_short High prevalence of HIV-1 transmitted drug resistance among therapy-naïve Burmese entering travelers at Dehong ports in Yunnan, China
title_sort high prevalence of hiv-1 transmitted drug resistance among therapy-naïve burmese entering travelers at dehong ports in yunnan, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941624/
https://www.ncbi.nlm.nih.gov/pubmed/29739342
http://dx.doi.org/10.1186/s12879-018-3130-9
work_keys_str_mv AT xuanqicai highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT liangshuwen highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT qinweihong highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT yangshuting highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT zhangamei highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT zhaoting highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT suhui highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT xiazhiqing highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT wangbinghui highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina
AT xiaxueshan highprevalenceofhiv1transmitteddrugresistanceamongtherapynaiveburmeseenteringtravelersatdehongportsinyunnanchina